THE CAROTID ARTERY
Prof Astarci Parla
Head of the Cardiovascular Department Cliniques Universitaires Saint-Luc Brussels
Cardiology 21 May 2016
THE CAROTID ARTERY Prof Astarci Parla Head of the Cardiovascular - - PowerPoint PPT Presentation
THE CAROTID ARTERY Prof Astarci Parla Head of the Cardiovascular Department Cliniques Universitaires Saint-Luc Brussels Cardiology 21 May 2016 Prof Astarci Parla Prof Astarci Parla Stroke Stroke = 90 000 death /year in France Third
Head of the Cardiovascular Department Cliniques Universitaires Saint-Luc Brussels
Cardiology 21 May 2016
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Stump Pressure and Somatosensory Evoked Potentials for Predicting the Use of Shunt During Carotid Surgery
Lacroix, A. Poncelet, J.C. Funken, D. Glineur, R. Verhelst Annals of Vascular Surgery May 2007 (Vol. 21, Issue 3, Pages 312-317)
Prof Astarci Parla
Prof Astarci Parla
– No modification 78.1% (225) – Middle modification 11.1% (32) – Severe modification 10.8% (31)
– Mean Stump Pressure 51 mmHg – Per-Op Shunt 16.3% (47patients) – Time without shunt 20 min – Delay clamp-SSEP 6 min – Time with shunt 31 min
Prof Astarci Parla
Stump Pressure and Somatosensory Evoked Potentials for Predicting the Use of Shunt During Carotid Surgery
Lacroix, A. Poncelet, J.C. Funken, D. Glineur, R. Verhelst Annals of Vascular Surgery May 2007 (Vol. 21, Issue 3, Pages 312-317)
RESULTS
91.3% (263/288)
8.3% (24/288)
0.3% (1/288)
Prof Astarci Parla
TEA for carotid stenosis (june)
Prof Astarci Parla
– Warlow: Is it safe to auscultate the neck? – Callow: Carotid endarterectomy: an expression of concern – Sandercock: Asymptomatic carotid stenosis: spare the knife
– NASCET – ECST
Prof Astarci Parla
– 659 symptomatic patients with > 70% stenosis (1991) » Perioperative stroke and mortality: 5.8% Death: 0,6% Major stroke:1,5% » 2 years follow-up: ipsilateral stroke-rate Medical: 26 % Surgical: 9% (p<0.05)
North American Symptomatic Carotid Trial
– 2226 symptomatic patients with 30-70% stenosis (1998) » 50-70%: 5 year stroke rate: Medical: 22.2% Surgical: 15.7% (p<0.05)
» <50%: No significant benefit even at 5 years
Prof Astarci Parla
–778 symptomatic patients with > 70% stenosis (1991) »Perioperative stroke and mortality: 7.5% Death: 0,9% Major stroke: 3,7% »3 years follow-up: death and stroke-rate: Medical: 21.9% Surgical: 12.9% (p<0.05)
European Carotid Surgery Trial
–3023 symptomatic patients with 30-70% (1998) »Perioperative stroke and mortality: 7.0% »50-70% stenosis: 3 year stroke-rate Medical: 26.5% Surgical: 14.9% (p<0.05)
»No benefit for < 50% stenosis
Prof Astarci Parla
Measurement differences between ESCT and Nascet
Prof Astarci Parla
■ Multicentric, selected team, 5 year follow-up ■ Asymptomatic Stenosis >70% ■ Randomised but no high surgical risk ■ 3120 pts -> 1560 CEA
1560 medical care Stroke rate at 5 years CEA:3,1% / Medical care:11% High significant reduction at 5-year risk (p<0.01)
Prof Astarci Parla
Evidence for CEA in asymptomatic patients
– 1662 asymptomatic patients > 70 % stenosis – Peri-operative stroke and death: 2,3 % (1,2% due to angiography !) – 5-year stroke-rate: Medical : 10,6% Surgical: 4,8% p<0.05 only after 5 years
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
–Angioplasty alone –Stenting ( after 1990 ) –Low profile systems … –Protection devices (Théron 1987) –?
Prof Astarci Parla
– 1981: 1st case – 1994: 305 cases: 2% neurological complications (Radiology) – 1999: 799 cases: 7,7% neurological complications (Radiologe)
– 1987: 11 cases – 1992: 123 cases: 2% complications (Int. Neuroradiology) – 1996: 174 cases: 4% neurological complications (J.Mal.Vasc) – 1998: 218 cases: 4,5% neurological complications (Marseille)
– 1998: 173 cases: 4,6% neurological complications (J Endovasc Surg) – 2000: 315 cases: 4,5% neurological complications (Texas Heart J)
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
■ Prospective, randomized, sympto + asympto ■ 307 ppts -> 157 stenting
151 CEA
■ 33% symptomatic and 67% asymtomatic
EXCLUSION criteria:
congestive heart failure (NYHA III/IV), LVEF <30%, Cardiac surgery within 6 week Recent MI, Unstable angina Severe pulmonary disease Contralat carotid occlusion Contralat laryngeal nerve palsy, Radiation therapy of the neck, Radical neck surgery Previous endarterectomy with recurrent stenosis High cervicall ICA stenosis or CCA lesions below the clavicle Severe tandem lesions Age>80
SAPPHIRE The Stenting and Angioplasty with Protection in Patients at High risk for endarterectomy N Engl J Med. 2004 Oct 7;351(15):1493-501.
Prof Astarci Parla
Lower incidence of 30-days adverse events:
CAS CEA stroke 3.8 5.3 death 0.6 2 MI 2.6 7.3
Combined risk for CAS: 6.4% versus CEA: 12.6% p<0.05
p=NS p=NS p=NS
Prof Astarci Parla
■ Multicentric, non randomised USA ■ Symptomatic + Asymptomatic ■ 143 CAS+EPD (31% sympto,84% high risk)
Wallstent Boston - Guidewire Plus Medtronic
■ 254 CEA (33% sympto, 87% high risk)
Stroke/death rate 30 days:3,6% CEA – 2,1% CAS but p=NS Mi 30 days, stroke/death 1 year, restenosis: ns
CaRESS Carotid Revascularisation using endarterectomy or stenting systems
J Vasc Surg. 2005 Aug;42(2):213-9.
Prof Astarci Parla
■ Symptomatic, randomised ■ 1200 pts à 605 CAS
à 595 CEA Stroke/death rate 30 days: 6.8% CAS 6.34% CEA (p=0.09)
SPACE Stent-Protected Angioplasty versus Carotid Endarterectomy in symptomatic patients
Prof Astarci Parla
■ Multicentric ■ Symptomatic stenosis, 60-99 % ■ Randomized: CEA-CAS ! started 2000 but systematic use of EPD since 2003 ■ Team: neuro:follow-up/Vasc surg: >25 CEA/year/Intervent:>12 stent ■ 514 pts -> 257 CEA
247 CAS CEA 30-day stroke/death 3,9% CAS 9,6% (7,9% if EPD- 25% without EPD) CEA disabling stroke/death 1,5% CAS 3,4% p = NS local or systemic complications Study was stopped!
EVA-3S Endarterectomy versus Stenting in patients with Symptomatic Severe Carotid Stenosis…
N Engl J Med. 2006 Oct 19;355(16):1660-71.
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
Prof Astarci Parla
symptomatic and asymptomatic carotid stenosis
asymptomatic lesions in selected cases.
Prof Astarci Parla
Prof Astarci Parla